Angiotensin-converting enzyme 2 (ACE2) : COVID 19 gate way to multiple organ failure syndromes

Copyright © 2020 Elsevier B.V. All rights reserved..

BACKGROUND: Globally, the current medical emergency for novel coronavirus 2019 (COVID-19) leads to respiratory distress syndrome and death.

PURPOSE: This review highlighted the effect of COVID-19 on systemic multiple organ failure syndromes. This review is intended to fill a gap in information about human physiological response to COVID-19 infections. This review may shed some light on other potential mechanisms and approaches in COVID -19 infections towards systemic multiorgan failure syndromes.

FINDING: SARS-CoV-2 intervened mainly in the lung with progression to pneumonia and acute respiratory distress syndrome (ARDS) via the angiotensin-converting enzyme 2(ACE2) receptor. Depending on the viral load, infection spread through the ACE2 receptor further to various organs such as heart, liver, kidney, brain, endothelium, GIT, immune cell, and RBC (thromboembolism). This may be aggravated by cytokine storm with the extensive release of proinflammatory cytokines from the deregulating immune system.

CONCLUSION: The widespread and vicious combinations of cytokines with organ crosstalk contribute to systemic hyper inflammation and ultimately lead to multiple organ dysfunction (Fig. 1). This comprehensive study comprises various manifestations of different organs in COVID-19 and may assist the clinicians and scientists pertaining to a broad approach to fight COVID 19.

Medienart:

E-Artikel

Erscheinungsjahr:

2021

Erschienen:

2021

Enthalten in:

Zur Gesamtaufnahme - volume:283

Enthalten in:

Respiratory physiology & neurobiology - 283(2021) vom: 06. Jan., Seite 103548

Sprache:

Englisch

Beteiligte Personen:

Loganathan, Sundareswaran [VerfasserIn]
Kuppusamy, Maheshkumar [VerfasserIn]
Wankhar, Wankupar [VerfasserIn]
Gurugubelli, Krishna Rao [VerfasserIn]
Mahadevappa, Vidyashree Hodagatta [VerfasserIn]
Lepcha, Lhakit [VerfasserIn]
Choudhary, Arbind Kumar [VerfasserIn]

Links:

Volltext

Themen:

ACE2
ACE2 protein, human
ARDS
Angiotensin-Converting Enzyme 2
COVID-19
Cytokines
EC 3.4.15.1
EC 3.4.17.23
Journal Article
Peptidyl-Dipeptidase A
Pneumonia and inflammation
Review
SARS-CoV-2
Spike Glycoprotein, Coronavirus
Spike protein, SARS-CoV-2

Anmerkungen:

Date Completed 26.11.2020

Date Revised 14.03.2023

published: Print-Electronic

Citation Status MEDLINE

doi:

10.1016/j.resp.2020.103548

funding:

Förderinstitution / Projekttitel:

PPN (Katalog-ID):

NLM31528112X